Published in Br Med J on August 31, 1974
Symmetrical peripheral gangrene. Br Heart J (1977) 1.49
Myeloproliferative disorders: a paradox of in-vivo and in-vitro platelet function. J Clin Pathol (1977) 1.05
Thrombocytosis in rheumatoid arthritis. Recurrent arterial thromboembolism and death. Ann Rheum Dis (1977) 1.00
Spontaneous platelet aggregation reversed by flurbiprofen. Br Med J (1978) 0.95
Gangrene of the toes with palpable peripheral pulses. Ann Surg (1981) 0.83
The prostanoids in hemostasis and thrombosis: a review. Am J Pathol (1980) 0.83
Potential therapeutic applications of aspirin and other cyclo-oxygenase inhibitors. Br J Clin Pharmacol (1980) 0.77
Superior sagittal sinus thrombosis and essential thrombocythaemia. Br Med J (Clin Res Ed) (1983) 0.77
Non-surgical management of peripheral vascular disease. Br Med J (Clin Res Ed) (1981) 0.75
Antiplatelet agents in the treatment of thrombotic complications of primary thrombocythemia. Can Med Assoc J (1979) 0.75
An ulceronecrotic foot lesion in a patient with essential thrombocythemia: successful treatment with hydroxyurea. Case Rep Dermatol (2012) 0.75
Haemorrhagic thrombocythaemia: a clinical and laboratory study. Br J Haematol (1955) 2.42
Hemorrhagic thrombocythemia: a critical review. Blood (1960) 1.55
The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo. Clin Sci Mol Med (1973) 1.42
Aspirin and recurrent painful toes and fingers in thrombocythaemia. Lancet (1972) 1.33
Inhibition by aspirin of release of antiheparin activity from human platelets. Br Med J (1969) 1.25
Haemorrhagic thrombocythaemia and its treatment with radioactive phosphorus. Q J Med (1962) 1.14
Factor VIII gene rearrangements in patients with severe haemophilia A. Lancet (1994) 3.56
Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol (1993) 3.36
Hepatitis C antibody and chronic liver disease in haemophilia. Lancet (1990) 2.44
Cerebral intravascular coagulation in diabetic ketoacidosis. Lancet (1974) 2.35
Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet (1985) 2.26
Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation. Thromb Haemost (1998) 2.20
Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability. Thromb Haemost (1999) 2.15
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost (2005) 2.13
The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol (1996) 1.76
Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost (1998) 1.71
Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates. Lancet (1990) 1.69
Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease. Lancet (1980) 1.68
Thromboplastin related differences in the determination of international normalised ratio: a cause for concern? Steering Committee of the UK National External Quality Assessment Scheme in Blood Coagulation. Thromb Haemost (1994) 1.67
Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol (1990) 1.64
Thrombocytosis, circulating platelet aggregates, and neurological dysfunction. Br Med J (1979) 1.59
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Percutaneous liver biopsy and chronic liver disease in haemophiliacs. Lancet (1978) 1.53
Nephritis in two children after irradiation and chemotherapy for nephroblastoma. Lancet (1974) 1.47
Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost (2004) 1.44
Automated exchange transfusion for life-threatening plasmodium falciparum malaria--lessons relating to prophylaxis and treatment. J Infect (1999) 1.44
G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial. Br J Haematol (1997) 1.42
Hyposplenism in inflammatory bowel disease. Gut (1978) 1.36
High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis. Br J Haematol (1994) 1.29
Cellular hyperviscosity as a cause of neurological symptoms in leukaemia. Br Med J (1978) 1.27
Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. N Engl J Med (1981) 1.22
The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest (1985) 1.22
Sodium valproate and thrombocytopenia. Br Med J (1976) 1.21
Progressive liver disease in haemophilia: an understated problem? Lancet (1985) 1.19
A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs. Blood (1991) 1.19
Intravascular coagulation and E. coli septicaemia. J Clin Pathol (1973) 1.18
Platelet abnormalities in diabetic peripheral neuropathy. Lancet (1975) 1.18
A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin. Br J Haematol (2001) 1.17
Hyposplenism in ulcerative colitis. Lancet (1974) 1.15
Evidence against vitamin K deficiency in normal neonates. Thromb Haemost (1980) 1.13
Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease. Br J Rheumatol (1988) 1.11
Cerebral involvement with disseminated intravascular coagulation in intestinal disease. J Clin Pathol (1977) 1.09
The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin. Br J Clin Pharmacol (1988) 1.07
Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases. Br J Haematol (1983) 1.07
Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet (1987) 1.07
Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis. Clin Exp Immunol (1989) 1.07
Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology. J Clin Pathol (1993) 1.06
Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. J Thromb Haemost (2003) 1.06
Disseminated intravascular coagulation as a consequence of cerebral damage. J Neurol Neurosurg Psychiatry (1974) 1.06
Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation. Blood (1998) 1.04
Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins. Br J Clin Pharmacol (1986) 1.04
Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet (1978) 1.03
Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts. Br J Haematol (1992) 1.02
Relationship between splenic size and splenic function. Gut (1978) 1.02
A reassessment of vascular factors in relation to intravascular coagulation. Diabetologia (1976) 1.02
Microvascular thrombosis of the bowel in paroxysmal nocturnal haemoglobinuria. J Clin Pathol (1987) 1.02
Mesenteric infarction due to combined protein C deficiency and prothrombin 20210 defects. Postgrad Med J (1999) 1.01
The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. Atherosclerosis (1985) 1.01
Effects of epoxymethano analogues of prostaglandin endoperoxides on aggregation, on release of 5-hydroxytryptamine and on the metabolism of 3',5'-cyclic AMP and cyclic GMP in human platelets. Biochim Biophys Acta (1979) 0.99
Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets. Nature (1977) 0.99
HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party. Thromb Haemost (1997) 0.99
Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome. Br J Haematol (1982) 0.99
Intrathoracic Hodgkin's disease presenting as hypertrophic osteoarthropathy. Br J Radiol (1976) 0.98
An electron microscopic study of the types and proportions of neurons in the cortex of the motor and visual areas of the cat and rat. Brain (1980) 0.97
Fatal cold anti-i autoimmune haemolytic anaemia complicating hairy cell leukaemia. Br J Haematol (2000) 0.97
Essential thrombocythaemia. Lancet (1982) 0.97
Severe disseminated intravascular coagulation associated with massive ventricular mural thrombus following acute myocardial infarction. Postgrad Med J (1988) 0.97
Precise carrier diagnosis in families with haemophilia A: use of conformation sensitive gel electrophoresis for mutation screening and polymorphism analysis. Thromb Haemost (1998) 0.97
Tentative protocol for the evaluation of coagulometers, based on one-stage prothrombin time. Clin Lab Haematol (1981) 0.97
Disseminated intravascular coagulation. Br J Hosp Med (1982) 0.97
Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage? Diabetologia (1987) 0.95
Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man. Thromb Res (1982) 0.95
Myelomatosis and the hyperviscosity syndrome. Br J Haematol (1978) 0.95
Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood (2000) 0.94
Rapid two-stage PCR for detecting factor V G1691A mutation. Lancet (1994) 0.94
Bone marrow aplasia in B cell chronic lymphocytic leukaemia: successful treatment with antithymocyte globulin. J Clin Pathol (1991) 0.94
Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost (1997) 0.94
Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation. Br J Haematol (1978) 0.93
Association between necropsy evidence of disseminated intravascular coagulation and coagulation variables before death in patients in intensive care units. J Clin Pathol (1988) 0.93
Late-form hemorrhagic disease of the newborn: a fatal case report with illustration of investigations that may assist in avoiding the mistaken diagnosis of child abuse. Am J Forensic Med Pathol (1999) 0.93
Serial changes in the coagulation system following clotting factor concentrate infusion. Thromb Diath Haemorrh (1975) 0.92
Familial thrombophilia: genetic risk factors and management. J Intern Med Suppl (1997) 0.92
Diagnostic accuracy of serum enzyme assays for myocardial infarction in a general hospital population. Br Heart J (1972) 0.92
Postpartum purpura fulminans: successful management with streptokinase. Br Med J (1973) 0.92
Detection by PCR of hepatitis C virus in factor VIII concentrates. Lancet (1990) 0.91
Oral methionine loading as a cause of acute serum folate deficiency: its relevance to parenteral nutrition. Postgrad Med J (1978) 0.91
The hypercoagulable state in clinical practice. Br J Haematol (1991) 0.91
The postnatal development of synapses in the visual cortex of the cat and the effects of eyelid closure. Brain Res (1981) 0.91
Atypical bullous pyoderma gangrenosum associated with myeloid malignancies. J Clin Pathol (1987) 0.91
Scrotal ulceration during all-trans retinoic (ATRA) therapy for acute promyelocytic leukaemia. Clin Lab Haematol (2000) 0.91
Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation. Thromb Haemost (1997) 0.90
The role of immunoglobulin G and fibrinogen in platelet aggregation by Streptococcus sanguis. Br J Haematol (1997) 0.90
Protein C and protein S in homozygous sickle cell disease: does hepatic dysfunction contribute to low levels? Br J Haematol (1997) 0.90
A rapid method for haemophilia B mutation detection using conformation sensitive gel electrophoresis. Br J Haematol (1999) 0.90
Bleeding time in patients with hepatic cirrhosis. BMJ (1990) 0.90